The Enterprise Value as of December 2024 (TTM) for CSL Limited (CMXHF) is 95.55B

According to CSL Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 95.55B. This represents a change of -9.24% compared to the average of 105.28B of the last 4 quarters.

CSL Limited (CMXHF) Historical Enterprise Value (quarterly & annually)

How has CMXHF Enterprise Value performed in the past?

The mean historical Enterprise Value of CSL Limited over the last ten years is 75.74B. The current 95.55B Enterprise Value has changed 12.52% with respect to the historical average. Over the past ten years (40 quarters), CMXHF's Enterprise Value was at its highest in in the December 2023 quarter at 106.01B. The Enterprise Value was at its lowest in in the June 2009 quarter at -1167997488.00.

CSL Limited (CMXHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CSL Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CSL Limited (CMXHF) Average Enterprise Value

How has CMXHF Enterprise Value performed in the past?

The current Enterprise Value of CSL Limited (CMXHF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

CSL Limited (CMXHF) Enterprise Value vs. Peers

How is CMXHF’s Enterprise Value compared to its peers?

CSL Limited’s Enterprise Value is greater than PMV Pharmaceuticals, Inc. (42.34M), less than Novo Nordisk A/S (2.82T), greater than KalVista Pharmaceuticals, Inc. (386.66M), greater than ProKidney Corp. (386.97M), greater than Ventyx Biosciences, Inc. (115.79M), greater than Bionomics Limited (1.43B), less than CSL Limited (95.55B), greater than Enzon Pharmaceuticals, Inc. (-34758664.00), greater than Legend Biotech Corporation (5.86B), greater than Zai Lab Limited (2.39B), greater than Seagen Inc. (42.84B), greater than Alnylam Pharmaceuticals, Inc. (30.97B), greater than Ascendis Pharma A/S (8.10B), greater than Beam Therapeutics Inc. (2.16B), greater than Intellia Therapeutics, Inc. (1.20B), greater than Editas Medicine, Inc. (43.78M), greater than Verve Therapeutics, Inc. (424.76M), greater than Prime Medicine, Inc. (304.95M),

Build a custom stock screener for CSL Limited (CMXHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CSL Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CSL Limited (CMXHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CSL Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.